Article
Erratic journey of CRISPR/Cas9 in oncology from bench-work to successful-clinical therapy
1 Jan 2021
Abstract excerpt
CRISPR is a customized molecular scissor, comprising genetic guide made of RNA and an enzyme, Cas9 which snips DNA in simpler, cheaper and more precise way than any other gene editing tools. In recent years CRISPR/Cas has taken the research world by storm being go-to genome editor for potential gene therapy to fix cancer as well as several hereditary disorders. This review explores the literature around the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
